Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL) Meeting Abstract


Authors: Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; Ahsanuddin, S.; Callan, D.; Freidin, B.; Porzio, R.; Dang, T. O.; Ni, A.; Rademaker, J.; Schoder, H.; Dogan, A.; Younes, A.
Abstract Title: Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 403s
Language: English
ACCESSION: WOS:000411931709031
DOI: 10.1200/JCO.2017.35.15_suppl.7544
PROVIDER: wos
Notes: Meeting Abstract: 7544 -- Source: Wos
Altmetric Score
MSK Authors
  1. Craig Moskowitz
    379 Moskowitz
  2. Steven M Horwitz
    382 Horwitz
  3. Heiko Schoder
    295 Schoder
  4. Andrew D Zelenetz
    571 Zelenetz
  5. Paul Hamlin
    183 Hamlin
  6. Matthew J Matasar
    134 Matasar
  7. David J Straus
    222 Straus
  8. Connie Wing-Ching Lee
    57 Lee
  9. Anas Younes
    221 Younes
  10. Devin Eileen Callan
    3 Callan
  11. Ahmet Dogan
    183 Dogan
  12. Thu-Oanh Thi Dang
    11 Dang
  13. Ai   Ni
    61 Ni
  14. Robert C Porzio
    2 Porzio
Related MSK Work